SAS® Product Drug Development Used in Healthcare

Drug Discovery and Development with SAS®

SAS provides a centralized, integrated solution for managing, analyzing, reporting and reviewing clinical research information. This solution enables life sciences organizations to make informed business decisions with confidence, to assess the safety and efficacy of research compounds more effectively, to collaborate across trials, phases and therapeutic areas successfully, and ultimately get better products to market faster.

Available Drug Discovery and Development Solutions from SAS:

SAS Drug Development provides an analysis and reporting solution that enables global collaboration with complete compliance and control. SAS OnDemand: Drug Development offers small and midsize businesses a centralized, controlled, Web-based solution for efficiently developing, executing and managing the transformation, analysis and submission of clinical research data.

SAS® Drug Development:

SAS Drug Development enables the collation and sharing of clinical research data throughout the entire organization via a well-managed, controlled, centralized repository. This single version of the truth enables rapid, efficient sharing of resources, data and knowledge across trials, phases and therapeutic areas at all stages of the clinical R&D process.

Benefits:

A single version of the truth. SAS Drug Development delivers full data integration and standardization via a centralized information repository that gives researchers throughout the organization direct access to both the research content and embedded intelligence tools at all stages of the clinical R&D process.

Full compliance with industry standards. SAS Drug Development provides the ability to meet industry expectations for managing research information content in accordance with government regulations, including 21 CFR Part 11, good industry practices (GxP) and sound business practices.

Automated integrity, traceability and transparency. The degree of transparency and traceability of all data analysis activities provided by the solution ensures ongoing quality control and quality assurance, and makes it easy to confidently address inquiries from regulatory agencies. More confidence in research decisions. Researchers can easily review multiple data sources to analyze research across trials, phases and therapeutic areas. This comprehensive view makes it easier to make go/no-go research program decisions earlier in the process.

Shorter development cycles. With the ability to make more confident decisions and analyze data from a single repository, researchers can reduce the time spent searching for, gathering and aggregating data for analysis. The solution also helps streamline and automate research and analysis tasks.

Download the complete SAS Drug Development Fact Sheet

How SAS Is Different

• A standardized, centralized repository. SAS Drug Development integrates data from all relevant sources, stores all information related to a clinical research program, and brings this information together in a standardized, centralized repository.
• Streamlined processes. By providing immediate access and ongoing insight into project progress, SAS Drug Development gives organizations better control over the deployment of resources, as well as the streamlining of clinical R&D processes and tasks.
• Integrated SAS® program development and execution. An embedded program development environment provides the ability to easily develop SAS programs and macro libraries, review log files and test program functionality.
• A truly collaborative environment. Research scientists and less technical users have direct access to research data, statistical results and all other relevant clinical research content via a secure, user-friendly interface.
• Full compliance. SAS Drug Development was carefully designed to meet existing and emerging government regulations, including 21 CFR Part 11, as well as good industry practices and sound business methodologies.

Only SAS provides a secure, collaborative framework that puts controlled power into the hands of researchers who need it. The result is greater productivity and efficiency in these areas:

• Integration. Efficiently integrate and manage data from a wide range of sources – such as electronic data capture (EDC) systems, in-house clinical data management systems (CDMS), labs and contract research organizations (CROs) – while leveraging investments in existing systems and resources.
• Analysis and reporting. Accurately assess and report on study data in a timely manner. Efficiently generate presentation-ready statistical summaries of clinical trials data and easily share results with researchers or reviewers on demand.
• Discovery. Use your growing research information repository to rapidly investigate critical drug safety issues, pursue new marketing claims and explore potential product-line extensions.
• Regulatory compliance. Document research content via integrated processes that provide versioning, audit trails and electronic signatures, as well as fully describing the relationships between all process inputs, transformations, analyses and results.

Note: The matter has been taken from the SAS® Site